Interferon β-1a subcutaneously 3 times/week clinical outcome in relapsing multiple sclerosis in Finland

Prognostic factors and long-term treatment response of interferon β-1a s.c tiw has not been studied in a real-life clinical cohort in Finland. The aim of the paper was to evaluate long-term treatment response, prognostic clinical factors and adherence among interferon β-1a s.c tiw treated patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Järvinen, Elina, Murtonen, Annukka, Tervomaa, Melina, Sumelahti, Marja-Liisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908953/
https://www.ncbi.nlm.nih.gov/pubmed/31871598
http://dx.doi.org/10.4081/ni.2019.8177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908953/
https://www.ncbi.nlm.nih.gov/pubmed/31871598
http://dx.doi.org/10.4081/ni.2019.8177

Ejemplares similares